发明申请
- 专利标题： SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE
- 专利标题（中）： 持续释放ZIPRASIDONE剂量
-
申请号： US12261678申请日： 2009-09-03
-
公开(公告)号： US20100003331A1公开(公告)日： 2010-01-07
- 发明人: Imran Ahmed , Leah Elizabeth Appel , Walter Christian Babcock , Dwayne Thomas Friesen , Scott Herbig , David Keith Lyon , Sheri L. Shamblin , Ravi Mysore Shanker , Daniel Tod Smithey , Steven C. Sutton , Avinash Govind Thombre , Kenneth C. Waterman , Jaymin C. Shah , Parag Suresh Shah , Peter Wisniecki , Dawn Renee Wagner
- 申请人： Imran Ahmed , Leah Elizabeth Appel , Walter Christian Babcock , Dwayne Thomas Friesen , Scott Herbig , David Keith Lyon , Sheri L. Shamblin , Ravi Mysore Shanker , Daniel Tod Smithey , Steven C. Sutton , Avinash Govind Thombre , Kenneth C. Waterman , Jaymin C. Shah , Parag Suresh Shah , Peter Wisniecki , Dawn Renee Wagner
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 主分类号： A61K9/14
- IPC分类号： A61K9/14 ; A61K31/501
摘要：
A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
信息查询
